Americas

Argentina

Spanish

Brazil

Portuguese

Canada

Chile

Spanish

Colombia

Spanish

Mexico

Spanish

Peru

Spanish

United States

English

Asia Pacific

Europe

Austria

German

Belgium

Czech Republic

Czech

Denmark

Danish

Finland

Finnish

France

French

Germany

German

Greece

Greek

Hungary

Hungarian

Ireland

English

Italy

Italian

Luxembourg

English

Netherlands

Norway

Norwegian

Poland

Polish

Portugal

Portuguese

Romania

Romanian

Spain

Spanish

Sweden

Swedish

Switzerland

United Kingdom

English

Middle East

Israel

Hebrew

Saudi Arabia

Turkey

Turkish

United Arab Emirates

Other

Other Markets

Distributor Markets
Our Medicines

Other markets

As a multinational BioPharma company, we operate either directly or through distributor partners in many countries. For contact information in the countries where Bristol Myers Squibb does not have a local office please contact our third party business partners from the drop-down menu.


Bosnia and Herzegovina

Amicus Pharma d.o.o.
Fra Anđela Zvizdovića 1
71000 Sarajevo
Tel. +387 33 257 810
bih.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

Bulgaria

Swixx Biopharma EOOD
Sterling Serviced Office Group
48 Sitnyakovo Blvd.
Serdika center – 10th floor
Serdika Mall
1505 Sofia
Tel. +359 2 4942 480

bulgaria.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

Croatia

Swixx Biopharma d.o.o.
Savska 32
10000 Zagreb
Tel. +385 1 2078 500 Tel. +385 1 2078 508
croatia.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

Estonia

Swixx Biopharma OÜ
Tornimäe 5 – 2
10145 Tallinn
Tel. +372 640 1030

estonia.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

Egypt

Fattal Office/Medscience
48 Elhoreya St., Almaza, Heliopolis,
6th floor, Flat 12. Cairo-Egypt
Tel. +20224146784

Iceland

VISTOR
Horgatun 2
210 Gardabear, Island

http://vistor.is


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

Jordan

Orient Drug Store
P.O. Box 590, Nimer El Edwan St.
Jabal El Weibdeh El Gharbi, Amman 11118-Jordan
Tel. +96 26 465 2000

Latvia

Swixx BioPharma SIA
Valdemara iela 33 – 18A
Riga, LV-1010
Tel. +371 67708347
latvia.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

Lebanon

Pacific Pharma
Hussein Oueyni st, Ras Beirut, Beirut, Lebanon
Tel. +961-1-806640 | +961-1-788976
Email:
pacific@terra.net.lb

Lithuania

Swixx Biopharma UAB
Bokšto 1-3
Vilnius
Tel. +370 5 236 9140
lithuania.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

Malta

A.M. Mangion Ltd.
Mangion Building,
N/S off Valletta Road,
Luqa, LQA 6000, Malta

http://ammangion.com.mt


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

North Macedonia


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

Serbia

Amicus SRB d.o.o.
Milorada Jovanovica
911000 Belgrade
Tel. +381 11 4426 300 Tel. +381 11 4426 301
serbia.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

Slovakia

Swixx Biopharma s. r. o.
Eurovea Central 3
Pribinova 10
811 09 Bratislava, Slovakia
Tel. +421 2 20833 600
slovakia.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

Slovenia

Swixx Biopharma d.o.o.
Pot k sejmišču
351231 Ljubljana – Črnuče
Tel. +386 1 2355 100
slovenia.info@swixxbiopharma.com


BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

EFPIA 2023
Methodology Document 2023

EFPIA 2022
Methodology Document 2022

Ukraine



BMS Transparency Disclosures

EFPIA 2024
Methodology Document 2024

Venezuela

DROVITAL CASA DE REPRESENTACIÓN, C.A.
Oficina A, Planta Intermedia, Torre Financiera, Avenida Beethoven, Urbanización Colinas de Bello Monte,
Municipio Baruta, área metropolitana de Caracas, Venezuela.
Tel. +58 (212) 751 3202
Email: blanca.berrios@drovitalcr.com

AltStyle によって変換されたページ (->オリジナル) /